CpG island hypermethylation of the neurofibromatosis type 2 (NF2) gene is rare in sporadic vestibular schwannomas
- PMID: 20831745
- DOI: 10.1111/j.1365-2990.2010.01090.x
CpG island hypermethylation of the neurofibromatosis type 2 (NF2) gene is rare in sporadic vestibular schwannomas
Abstract
Aims: Loss of both wild-type copies of the neurofibromatosis type 2 (NF2) gene is found in both sporadic and neurofibromatosis type 2-associated vestibular schwannomas (VS). Previous studies have identified a subset of VS with no loss or mutation of NF2. We hypothesized that methylation of NF2 resulting in gene silencing may play a role in such tumours.
Methods: Forty sporadic VS were analysed by array comparative genomic hybridization using 1 Mb whole genome and chromosome 22 tile path arrays. The NF2 genes were sequenced and methylation of NF2 examined by pyrosequencing.
Results: Monosomy 22 was the only recurrent change found. Twelve tumours had NF2 mutations. Eight tumours had complete loss of wild-type NF2, four had one mutated and one wild-type allele, 11 had only one wild-type allele and 17 showed no abnormalities. Methylation analysis showed low-level methylation in four tumours at a limited number of CpGs. No high-level methylation was found.
Conclusions: This study shows that a significant proportion of sporadic VS (>40%) have unmethylated wild-type NF2 genes. This indicates that other mechanisms, yet to be identified, are operative in the oncogenesis of these VSs.
© 2010 The Authors. Neuropathology and Applied Neurobiology © 2010 British Neuropathological Society.
Similar articles
-
Lack of neurofibromatosis type 2 gene promoter methylation in sporadic vestibular schwannomas.ORL J Otorhinolaryngol Relat Spec. 2012;74(1):33-7. doi: 10.1159/000334968. Epub 2012 Jan 13. ORL J Otorhinolaryngol Relat Spec. 2012. PMID: 22249120
-
Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.Oncogene. 2010 Nov 25;29(47):6216-21. doi: 10.1038/onc.2010.363. Epub 2010 Aug 23. Oncogene. 2010. PMID: 20729918
-
Should NF2 mutation screening be undertaken in patients with an apparently isolated vestibular schwannoma?Clin Genet. 2007 Apr;71(4):354-8. doi: 10.1111/j.1399-0004.2007.00778.x. Clin Genet. 2007. PMID: 17470137
-
Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.Glia. 1995 Nov;15(3):297-307. doi: 10.1002/glia.440150310. Glia. 1995. PMID: 8586465 Review.
-
The molecular biology of vestibular schwannomas: dissecting the pathogenic process at the molecular level.Otol Neurotol. 2006 Feb;27(2):197-208. doi: 10.1097/01.mao.0000180484.24242.54. Otol Neurotol. 2006. PMID: 16436990 Review.
Cited by
-
Current molecular understanding of central nervous system schwannomas.Acta Neuropathol Commun. 2025 Feb 5;13(1):24. doi: 10.1186/s40478-025-01937-w. Acta Neuropathol Commun. 2025. PMID: 39910685 Free PMC article. Review.
-
Updates on Tumor Biology in Vestibular Schwannoma.Otolaryngol Clin North Am. 2023 Jun;56(3):421-434. doi: 10.1016/j.otc.2023.02.004. Otolaryngol Clin North Am. 2023. PMID: 37121611 Free PMC article. Review.
-
Brainstem intraparenchymal schwannoma with genetic analysis: a case report and literature review.BMC Med Genomics. 2021 Aug 18;14(1):205. doi: 10.1186/s12920-021-01049-z. BMC Med Genomics. 2021. PMID: 34407809 Free PMC article. Review.
-
Genomics, Epigenetics, and Hearing Loss in Neurofibromatosis Type 2.Otol Neurotol. 2020 Jun;41(5):e529-e537. doi: 10.1097/MAO.0000000000002613. Otol Neurotol. 2020. PMID: 32150022 Free PMC article. Review.
-
Contemporary Molecular Biology of Sporadic Vestibular Schwannomas: A Systematic Review and Clinical Implications.J Int Adv Otol. 2018 Aug;14(2):322-329. doi: 10.5152/iao.2018.4929. J Int Adv Otol. 2018. PMID: 30100540 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous